Clinical Trials
2 trialsNCT02286219 2017-09-18
Phase 1, Multiple Ascending Dose Study of Anti-HER2 FCAB FS102 in HER2 Positive Solid Tumors (Anti HER2 Fcab)
Bristol-Myers Squibb
Phase 1 Completed
NCT01804829 2017-03-15
Civacir® Polyclonal Immune Globulin (IgG) to Prevent Hepatitis C Virus (HCV) Recurrence in Liver Transplant Patients.
Biotest Pharmaceuticals Corporation
Phase 3 Completed